Structure and mutation analysis of the gene encoding DNA fragmentation factor 40 (caspase-activated nuclease), a candidate neuroblastoma tumour suppressor gene

Human Genetics

Volumn 106, Issue 4, 2000, Pages 406-413

  Judson, Hannah ^a   Van Roy, Nadine ^b   Strain, Lisa ^c   Vandesompele, Jo ^b   Van Gele, Mireille ^b   Speleman, Frank ^b   Bonthron, David T ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; NUCLEASE;

APOPTOSIS; ARTICLE; CHROMOSOME 1P; CHROMOSOME 9; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; GENETIC CODE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL; PSEUDOGENE; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 0034111601     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390000257     Document Type: Article

References (43)

1. Arden KC, Viars CS, Weiss S, Argentin S, Nemer M (1995) Localization of the human B-type natriuretic peptide precursor (NPPB) gene to chromosome 1p36. Genomics 26:385-389
2. Bieche I, Khodja A, Lidereau R (1998) Deletion mapping in breast tumor cell lines points to two distinct tumor-suppressor genes in the 1p32-pter region, one of deleted regions (1p36.2) being located within the consensus region of LOH in neuroblastoma. Oncol Res 5:267-272
3. Brodeur GM (1995) Genetics of embryonal tumours of childhood: retinoblastoma, Wilms' tumour and neuroblastoma. Cancer Surveys 25:67-99
4. Brodeur GM, Fong CT (1989) Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet 41:153-174
5. Campbell R, Gosden CM, Bonthron DT (1994) Parental origin of transcription from the human GNAS1 gene. J Med Genet 31:607-614
6. Caron H, Sluis P van, Hoeve M van, Kraker J de, Bras J, Slater R, Mannens M, Voute PA, Westerveld A, Versteeg R (1993) Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nat Genet 4:187-190
7. Caron H, Peter M, Sluis P van, Speleman F, Kraker J de, Laureys G, Michon J, Brugieres L, Voute PA, Westerveld A, Slater R, Delattre O, Versteeg R (1995) Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum Mol Genet 4:535-539
8. Caron H, Sluis P van, Kraker J de, Bokkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voute PA, Versteeg R (1996) Allelic loss of chromosome 1p as a predictor of unfavourable outcome in patients with neuroblastoma. N Engl J Med 334:225-230
9. Cheng NC, Van Roy N, Chan A, Beitsma M, Westerveld A, Speleman F, Versteeg R (1995) Deletion mapping in neuroblastoma cell lines suggests two distinct tumour suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification. Oncogene 10:291-297
10. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43-50
11. Gasparian AV, Laktionov KK, Belialova MS, Pirogova NA, Tatosyan AG, Zborovskaya IB (1998) Allelic imbalance and instability of microsatellite loci on chromosome 1p in human non-small-cell lung cancer. Br J Cancer 77: 1604-1611
12. Gingrich JC, Boehrer D, Garnes JA, Johnson W, Wong B, Bergmann A, Eveleth GG, Longlois RG, Carrano AV (1996) Construction and characterisation of human chromosome 2-specific cosmid, fosmid, and PAC clone libraries. Genomics 32:65-74
13. Halenbeck R, MacDonald H, Roulston A, Chen TT, Conroy L, Williams LT (1998) CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45. Curr Biol 8:537-540
14. Hayward BE, Kamiya M, Strain L, Moran V, Campbell R, Hayashizaki Y, Bonthron DT (1998) The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins. Proc Natl Acad Sci USA 95:10038-10043
15. Ioannou PA, Amemiya CT, Games J, Kroisel PM, Shizuya H, Chen C, Batzer MA, Jong PJ de (1994) A new bacteriophage P1-derived vector for the propagation of large human DNA fragments. Nat Genet 6:84-89
16. Jost CA, Marin MC, Kaelin WG (1997) p73 is a human p53-related protein that can induce apoptosis. Nature 389:191-194
17. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumon X, Ferrara P, McKeon F, Caput D (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819
18. Kelsell DP, Rooke L, Warne D, Bouzyk M, Cullin L, Cox S, West L, Povey S, Spurr NK (1995) Development of a panel of monochromosomal somatic cell hybrids for rapid gene mapping. Ann Hum Genet 59:233-241
19. Kovalev S, Marchenko N, Swendeman S, LaQuaglia M, Moll UM (1998) Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. Cell Growth Differ 9:897-903
20. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H, Rakic P, Flavell RA (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384:368-372
21. Leek JP, Carr IM, Bell SM, Markham AF, Lench NJ (1997) Assignment of the DNA fragmentation factor gene (DFFA) to human chromosome bands 1p36.3->p36.2 by in situ hybridisation. Cytogenet Cell Genet 79:212-213
22. Liu X, Zou H, Slaughter C, Wang X (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89:175-184
23. Mai M, Qian C, Yokomizo A, Tindall DJ, Bostwick D, Polychronakos C, Smith DI, Liu W (1998) Loss of imprinting and allele switching of p73 in renal cell carcinoma. Oncogene 17:1739-1741
24. Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, Shuster JJ, Look AT, Brodeur GM (1995) Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Cancer Res 55:4664-4669
25. Maris JM, Jensen J, Sulman EP, Beltinger CP, Allen C, Biegel JA, Brodeur GM, White PS (1997) Human Kruppel-related 3 (HKR3): a candidate for the 1p36 neuroblastoma tumour suppressor gene? Eur J Cancer 33:1991-1996
26. Mukae N, Enari M, Sakahira H, Fukuda Y, Inazawa J, Toh H, Nagata S (1998) Molecular cloning and characterisation of human caspase-activated DNase. Proc Natl Acad Sci USA 95:9123-9128
27. Nagai H, Negrini M, Carter SL, Gillum DR, Rosenberg AL, Schwartz GF, Croce CM (1995) Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer. Cancer Res 55:1752-1757
28. Nomoto S, Haruki N, Kondo M, Konishi H, Takahashi T (1998) Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res 58:1380-1383
29. Ping YJ, Nakatsu Y, Goldstein AM, Tucker MA, Kraemer KH, Tanaka K (1998) RPA2, a gene for the 32 kDa subunit of replication protein A on chromosome 1p35-36, is not mutated in patients with familial melanoma linked to chromosome 1p36. Melanoma Res 8:47-52
30. Reik W, Maher ER (1997) Imprinting in clusters: lessons from Beckwith-Wiedemann syndrome. Trends Genet 13:330-334
31. Sakahira H, Enari M, Nagata S (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391:96-99
32. Schwab M, Praml C, Amler LC (1996) Genomic instability in 1p and human malignancies. Cancer Genet Cytogenet 16:211-229
33. Speleman F, Van Gele M, Maertens L, Van Roy N (1997) Improved protocol for the preparation of chromatin fibres from fixed cells. Technical Tips Online (URL: http://www.elsevier.com/locate/tto), T01123
34. Tahara H, Smith AP, Gaz RD, Zariwala M, Xiong Y, Arnold A (1997) Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate. J Bone Miner Res 12:1330-1334
35. Takita J, Hayashi Y, Yokota J (1997) Loss of heterozygosity in neuroblastomas - an overview. Eur J Cancer 33:1971-1973
36. Thompson FH, Taetle R, Trent JM, Liu Y, Massey-Brown K, Scott KM, Weinstein RS, Emerson JC, Alberts DS, Nelson MA (1997) Band 1p36 abnormalities and t(1;17) in ovarian carcinoma. Cancer Genet Cytogenet 96:106-110
37. Thrash-Bingham CA, Salazar H, Greenberg RE, Tartof KD (1996) Loss of heterozygosity studies indicate that chromosome arm 1p harbors a tumor suppressor gene for renal oncocytomas. Genes Chromosomes Cancer 16:64-67
38. Trask BJ, Engh G van den, Christensen M, Massa HF, Gray JW, Van Dilla MA (1991) Characterisation of somatic cell hybrids by bivariate flow karyotyping and fluorescence in situ hybridisation. Somat Cell Molec Genet 17:117-136
39. Van Gele M, Speleman F, Vandesompele J, Van Roy N, Leonard JH (1998a) Characteristic pattern of chromosomal gains and losses in Merkel cell carcinoma detected by comparative genomic hybridisation. Cancer Res 58:1503-1508
40. Van Gele M, Van Roy N, Ronan SG, Messiaen L, Vandesompele J, Geerts ML, Naeyaert JM, Blennow E, Bar-Am I, Das Gupta TK, Drift P van der, Versteeg R, Leonard JH, Speleman F (1998b) Molecular analysis of 1p36 breakpoints in two Merkel cell carcinomas. Genes Chromosomes Cancer 23:67-71
41. Van Roy N, Laureys G, Cheng NC, Willem P, Opdenakker G, Versteeg R, Speleman F (1994) 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer 10: 103-114
42. Vandesompele J, Van Roy N, Van Gele M, Laureys G, Ambros P, Heimann P, Devalck C, Schuuring E, Brock P, Otten J, Gyselinck J, DePaepe A, Speleman F (1998) Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridisation. Genes Chromosomes Cancer 23:141-152
43. Yang-Feng TL, Floyd-Smith G, Nemer M, Drouin J, Francke U (1985) The pronatriodilatin gene is located on the distal short arm of human chromosome 1 and on mouse chromosome 4. Am J Hum Genet 37:1117-1128